Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
76.75
+1.25 (1.66%)
At close: Dec 5, 2025, 4:00 PM EST
76.99
+0.24 (0.31%)
After-hours: Dec 5, 2025, 7:44 PM EST
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $5.18 billion as of December 5, 2025. Its market cap has increased by 95.67% in one year.
Market Cap
5.18B
Enterprise Value
4.60B
1-Year Change
95.67%
Ranking
Category
Stock Price
$76.75
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $5.18B, an increase of 540.35%. That is a compound annual growth rate of 116.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.18B | 100.94% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |